Amarin Corp Plcuk (AMRN) Receivables (2013 - 2026)

Amarin Corp Plcuk (AMRN) reported Receivables of $123.0 million for Q1 2026, up 15.31% year-over-year from $106.7 million in Q1 2025, and down 15.14% quarter-over-quarter from $145.0 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Receivables (2013 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 14 years of Receivables data on file, last reported at $123.0 million in Q1 2026.

  • Receivables for Q1 2026 came in at $123.0 million, up 15.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $123.0 million (up 15.31% YoY), and the FY2025 annual result was $145.0 million, up 8.95% from the prior year.
  • Receivables fell to $123.0 million in Q1 2026 per AMRN's latest filing, from $145.0 million in the prior quarter.
  • Over five years, Receivables peaked at $189.8 million in Q2 2022 and troughed at $106.7 million in Q1 2025.
  • A 5-year average of $134.8 million and a median of $131.0 million in 2022 frame the typical range for Receivables.
  • The sharpest annual moves came in 2022 and 2023: Receivables declined 27.15% in 2022, then climbed 22.67% in 2023.
  • A 5-year view of Receivables shows it stood at $131.0 million in 2022, then rose by 22.67% to $160.7 million in 2023, then fell by 17.19% to $133.1 million in 2024, then grew by 8.95% to $145.0 million in 2025, then dropped by 15.14% to $123.0 million in 2026.
  • Business Quant data shows AMRN's Receivables at $123.0 million in Q1 2026, $145.0 million in Q4 2025, and $127.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 10.46 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 21.18 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 17.72 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 12.48 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 12.21 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 9.14 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 5.33 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 12.59 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 9.52 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn 123.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 123.04 Mn
Dec 31, 2025 144.98 Mn
Sep 30, 2025 127.31 Mn
Jun 30, 2025 134.10 Mn
Mar 31, 2025 106.70 Mn
Dec 31, 2024 133.07 Mn
Sep 30, 2024 130.25 Mn
Jun 30, 2024 150.63 Mn
Mar 31, 2024 115.81 Mn
Dec 31, 2023 160.69 Mn
Sep 30, 2023 122.40 Mn
Jun 30, 2023 155.10 Mn
Mar 31, 2023 133.24 Mn
Dec 31, 2022 130.99 Mn
Sep 30, 2022 123.38 Mn
Jun 30, 2022 189.78 Mn
Mar 31, 2022 110.20 Mn
Dec 31, 2021 163.65 Mn
Sep 30, 2021 149.40 Mn
Jun 30, 2021 182.26 Mn